TCMD insider filings
TACTILE SYSTEMS TECHNOLOGY INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-09. Screen TCMD transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 4 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings by 2 insiders — 9,800 shares, $255,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
- Largest priced transaction: sale of 5,000 shares @ $27.00 ($135,000) by BURKE WILLIAM W, filed 2026-11-09.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| BURKE WILLIAM W — Director | 1 | — | 1 leg · 5,000 sh · $135,000 | — |
| King Laura G. — Director | 1 | — | 1 leg · 4,800 sh · $120,000 | — |
| Kiewiet Stephen A. — Chief Operating Officer | 2 | — | — | 1 |
Recent insider filings — TACTILE SYSTEMS TECHNOLOGY INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-09 | 4 | BURKE WILLIAM W — Director | Sale (S): 5,000 @ $27 | EDGAR |
| 2026-11-06 | 3 | Kiewiet Stephen A. — Chief Operating Officer | Holdings only — no transactions reported | EDGAR |
| 2026-11-06 | 4 | Kiewiet Stephen A. — Chief Operating Officer | Grant/award (A): 6,438 @ $0 | EDGAR |
| 2026-11-05 | 4 | King Laura G. — Director | Sale (S): 4,800 @ $25 | EDGAR |
| 2026-08-12 | 4 | Dodd Sheri Louise — Chief Executive Officer, Director | Sale (S): 10,978 @ $29.44 | EDGAR |
| 2026-05-13 | 4 | Birkemeyer Elaine M. — CHIEF FINANCIAL OFFICER | Sale (S): 4,631 @ $24.49 | EDGAR |
| 2026-05-08 | 4 | King Laura G. — Director | Grant/award (A): 6,521 @ $0 | EDGAR |
| 2026-05-08 | 4 | Washington Boyd Vindell — Director | Grant/award (A): 6,521 @ $0 | EDGAR |
| 2026-05-08 | 4 | Asbury Valerie L. — Director | Grant/award (A): 6,521 @ $0 | EDGAR |
| 2026-05-08 | 4 | Shafer David Brent — Director | Grant/award (A): 6,521 @ $0 | EDGAR |
| 2026-05-08 | 4 | Huggenberger Raymond — Director | Grant/award (A): 6,521 @ $0 | EDGAR |
| 2026-05-08 | 4 | Pearson Andrea — Director | Grant/award (A): 6,521 @ $0 | EDGAR |
| 2026-05-08 | 4 | Volkart Carmen B — Director | Grant/award (A): 6,521 @ $0 | EDGAR |
| 2026-05-08 | 4 | BURKE WILLIAM W — Director | Grant/award (A): 6,521 @ $0 | EDGAR |
| 2026-03-11 | 4 | Pearson Andrea — Director | Grant/award (A): 852 @ $0 | EDGAR |
| 2026-02-26 | 4 | Birkemeyer Elaine M. — CHIEF FINANCIAL OFFICER | Sale (S): 7,701 @ $28.94 | EDGAR |
| 2026-02-26 | 4 | Burns Kristie — Sr. VP Mktg & Clinical Affairs | Sale (S): 6,246 @ $28.94 | EDGAR |
| 2026-02-26 | 4 | Dodd Sheri Louise — Chief Executive Officer, Director | Sale (S): 10,993 @ $28.94 | EDGAR |
| 2026-02-24 | 4 | Birkemeyer Elaine M. — CHIEF FINANCIAL OFFICER | Grant/award (A): 3,579 @ $0 · Grant/award (A): 6,765 @ $0 · Grant/award (A): 15,575 @ $0 · Sale (S): 5,322 @ $28.28 · Sale (S): 196 @ $28.69 | EDGAR |
| 2026-02-24 | 4 | Burns Kristie — Sr. VP Mktg & Clinical Affairs | Grant/award (A): 3,490 @ $0 · Grant/award (A): 4,058 @ $0 · Grant/award (A): 7,123 @ $0 · Sale (S): 4,279 @ $28.28 · Sale (S): 160 @ $28.69 | EDGAR |
| 2026-02-24 | 4 | Dodd Sheri Louise — Chief Executive Officer, Director | Grant/award (A): 19,751 @ $0 · Grant/award (A): 28,216 @ $0 · Sale (S): 14,703 @ $28.28 · Sale (S): 537 @ $28.69 | EDGAR |
| 2026-02-23 | 4 | Birkemeyer Elaine M. — CHIEF FINANCIAL OFFICER | Grant/award (A): 23,008 @ $0 | EDGAR |
| 2026-02-23 | 4 | Burns Kristie — Sr. VP Mktg & Clinical Affairs | Grant/award (A): 6,194 @ $0 | EDGAR |
| 2026-02-23 | 4 | Dodd Sheri Louise — Chief Executive Officer, Director | Grant/award (A): 48,672 @ $0 | EDGAR |
| 2026-01-06 | 4 | Burns Kristie — Sr. VP Mktg & Clinical Affairs | Sale (S): 5,139 @ $28.85 | EDGAR |
| 2025-08-12 | 4 | Dodd Sheri Louise — Chief Executive Officer, Director | Sale (S): 7,762 @ $12.36 | EDGAR |
| 2025-05-14 | 4 | Birkemeyer Elaine M. — Chief Financial Officer | Sale (S): 2,921 @ $9.94 | EDGAR |
| 2025-05-12 | 4 | Dodd Sheri Louise — Chief Executive Officer, Director | Sale (S): 3,149 @ $9.83 | EDGAR |
| 2025-05-09 | 4 | Asbury Valerie L. — Director | Grant/award (A): 16,078 @ $0 | EDGAR |
| 2025-05-09 | 4 | BURKE WILLIAM W — Director | Grant/award (A): 16,078 @ $0 · Sale (S): 3,300 @ $9.67 | EDGAR |
| 2025-05-09 | 4 | Huggenberger Raymond — Director | Grant/award (A): 16,078 @ $0 | EDGAR |
| 2025-05-09 | 4 | King Laura G. — Director | Grant/award (A): 16,078 @ $0 | EDGAR |
| 2025-05-09 | 4 | Shafer David Brent — Director | Grant/award (A): 16,078 @ $0 | EDGAR |
| 2025-05-09 | 4 | Volkart Carmen B — Director | Grant/award (A): 16,078 @ $0 | EDGAR |
| 2025-05-09 | 4 | Washington Boyd Vindell — Director | Grant/award (A): 16,078 @ $0 | EDGAR |
| 2025-03-13 | 4 | REUVERS DANIEL L. — Director | Gift (G): 68,162 @ $0 · Gift (G): 68,162 @ $0 | EDGAR |
| 2025-02-27 | 4 | Birkemeyer Elaine M. — Chief Financial Officer | Sale (S): 2,066 @ $14.51 | EDGAR |
| 2025-02-27 | 4 | Burns Kristie — Sr. VP Mktg & Clinical Affairs | Sale (S): 6,468 @ $14.40 | EDGAR |
| 2025-02-27 | 4 | REUVERS DANIEL L. — Director | Sale (S): 28,338 @ $14.18 | EDGAR |
| 2025-02-24 | 4 | REUVERS DANIEL L. — Director | Grant/award (A): 15,853 @ $0 · Sale (S): 10,938 @ $14.55 | EDGAR |
| 2025-02-24 | 4 | Burns Kristie — Sr. VP Mktg & Clinical Affairs | Grant/award (A): 3,359 @ $0 · Grant/award (A): 4,131 @ $0 · Grant/award (A): 16,579 @ $0 · Sale (S): 4,830 @ $14.65 | EDGAR |
| 2025-02-24 | 4 | Birkemeyer Elaine M. — Chief Financial Officer | Grant/award (A): 3,446 @ $0 · Grant/award (A): 6,887 @ $0 · Grant/award (A): 36,248 @ $0 · Sale (S): 3,778 @ $14.70 | EDGAR |
| 2025-02-24 | 4 | King Laura G. — Director | Grant/award (A): 2,970 @ $0 | EDGAR |
| 2025-02-24 | 4 | Dodd Sheri Louise — Chief Executive Officer, Director | Grant/award (A): 20,108 @ $0 · Grant/award (A): 65,669 @ $0 | EDGAR |
| 2024-08-14 | 4 | Ferstler Sherri Lee — Senior VP, Sales | Sale (S): 1,550 @ $13.07 | EDGAR |
| 2024-08-09 | 4 | Dodd Sheri Louise — Chief Executive Officer, Director | Grant/award (A): 64,959 @ $0 | EDGAR |
| 2024-05-20 | 4 | Birkemeyer Elaine M. — Chief Financial Officer | Sale (S): 3,041 @ $13.68 | EDGAR |
| 2024-05-10 | 4 | Shafer David Brent — Director | Grant/award (A): 10,469 @ $0 | EDGAR |
| 2024-05-10 | 4 | Volkart Carmen B — Director | Grant/award (A): 10,469 @ $0 | EDGAR |
| 2024-05-10 | 4 | Washington Boyd Vindell — Director | Grant/award (A): 10,469 @ $0 | EDGAR |
Recent 8-K events — TACTILE SYSTEMS TECHNOLOGY INC
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-02 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-13 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-17 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-03 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TCMD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs